HPLC ≥99% · Mass-spec confirmed · Lot-matched COA
Cognitive & Nootropic Research
Semax 10mg
Semax is a heptapeptide derived from ACTH(4-10) with neuroprotective, neurogenic, and cognitive-enhancing properties, researched for various neurological conditions.
- SKU
- SEMAX_10MG
- Form
- Lyophilized powder
- Contents
- Pack of 1
- Purity
- ≥99%
- CAS
- 80714-61-0
- MW
- 837.93 g/mol
- Formula
- C37H51N9O11S
Storage: lyophilized −20°C · reconstituted 2–8°C, protect from light
Select size
Price
$49.99
In stock · ships in 24h
HPLC tested
Lot-matched COA
US ships in 24h
Semax is a synthetic analog of adrenocorticotropic hormone (ACTH) fragments, specifically focusing on its neuroregulatory properties without the hormonal activity of ACTH. Originating from Russia, it has been studied extensively in preclinical and clinical research settings for its potential to influence cognitive functions, mitigate stress responses, and protect neural tissue.
Researchers are particularly interested in Semax's multifaceted mechanisms, which appear to extend beyond simple neurotransmitter modulation. Its potential roles in enhancing brain-derived neurotrophic factor (BDNF) expression and modulating the immune system within the central nervous system are areas of active investigation.
Mechanism of Action
Semax primarily modulates the activity of several neurotransmitter systems, including dopaminergic and serotonergic pathways. It has been shown to increase the expression of synaptotagmin, a protein involved in neurotransmitter release, and BDNF in various brain regions. Additionally, Semax may influence opioid and melanocortin receptors, contributing to its diverse neuropharmacological profile under research conditions.
Structure and Class
Semax is a synthetic heptapeptide with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. This structure is derived from the ACTH(4-10) fragment, with additional proline-glycine-proline modifications designed to enhance its metabolic stability and blood-brain barrier permeability in research models. It belongs to the class of melanocortin mimetics.
Primary Research Areas
The primary research areas for Semax include its potential applications in nootropic, neuroprotective, and anxiolytic research. Investigators are studying its effects on memory formation, learning processes, and attention. Research also explores its role in neuroprotection against ischemic damage and its potential to modulate stress-induced behavioral alterations in animal models.
Notable Peer-Reviewed Findings
Numerous studies have indicated Semax's ability to enhance memory consolidation and retrieval in various animal models. Research has also demonstrated its neuroprotective effects against oxidative stress and ischemic injury, suggesting a role in preserving neuronal integrity. Furthermore, findings point to its potential in reducing anxiety-like behaviors and improving adaptive responses to stress in investigational settings.
Cognitive & Nootropic Research
Cognitive & nootropic research applications
Investigated for effects on neurogenesis, synaptic plasticity, and neuroprotection in cellular and rodent learning-and-memory models.
- BDNF/NGF expression and hippocampal LTP assays
- Acetylcholine, dopamine, and serotonergic signaling studies
- Neuroprotection against oxidative stress and excitotoxicity
- Maze, novel-object, and operant-learning paradigms in research cohorts
For laboratory research use only · not for human or veterinary use
Researcher reviews
No reviews yet — be the first.
Semax 10mg
$49.99


